Exploring the causes of liver cancer disparities among different racial and ethnic groups
Understanding the Multilevel Drivers of Liver Cancer Disparities
This study is looking into why liver cancer is rising, especially in minority communities, by examining health records and cancer data to find out what factors might be causing this increase, so we can help create better prevention strategies for those at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10671556 on NIH RePORTER |
What this research studies
This research investigates the increasing rates of hepatocellular carcinoma (HCC), particularly among minority racial and ethnic groups. By analyzing a large dataset that includes electronic health records and cancer registry data, the study aims to identify both established and emerging risk factors contributing to these disparities. The research will also explore the social and environmental factors that affect HCC surveillance and treatment. Ultimately, the goal is to inform prevention strategies that can reduce the burden of liver cancer in affected communities.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from minority racial and ethnic groups, particularly those with risk factors for liver cancer such as hepatitis infections, alcohol use, or metabolic disorders.
Not a fit: Patients who do not belong to the targeted racial and ethnic groups or who do not have the identified risk factors for liver cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted prevention strategies that significantly reduce liver cancer rates among high-risk populations.
How similar studies have performed: Previous research has shown success in addressing health disparities through similar multi-level analytical approaches, indicating the potential for impactful findings in this study.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Shariff-Marco, Salma — University of California, San Francisco
- Study coordinator: Shariff-Marco, Salma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.